Androgen class drugs

5 results

  • Androderm

    (Testosterone)
    Allergan, Inc.
    Usage: ANDRODERM is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various conditions affecting testosterone production, such as testicular failure or hormonal deficiencies. Its safety and efficacy in age-related hypogonadism and in males under 18 are not established.

  • Androgel

    (Testosterone)
    ASCEND Therapeutics U.S., LLC
    Usage: AndroGel 1.62% is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various conditions. Its safety and efficacy in age-related hypogonadism and in males under 18 have not been established.

  • Aveed

    (testosterone undecanoate)
    ENDO USA, Inc.
    Usage: AVEED is indicated for testosterone replacement therapy in adult males with conditions related to testosterone deficiency, including primary and hypogonadotropic hypogonadism. It should only be used when benefits outweigh risks, with safety and efficacy not established for age-related hypogonadism or in males under 18.

  • Jatenzo

    (testosterone undecanoate)
    TOLMAR Inc.
    Usage: JATENZO (testosterone undecanoate) is indicated for testosterone replacement therapy in adult males with conditions leading to low testosterone, including primary and hypogonadotropic hypogonadism. It is not established for safety and efficacy in males under 18 years old.

  • Natesto

    (testosterone)
    Acerus Pharmaceuticals Corporation
    Usage: Natesto is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various causes, such as testicular failure or pituitary-hypothalamic injury. Its safety and efficacy in age-related hypogonadism and in males under 18 years have not been established.